8-KOther Events

COHERENT CORP. 8-K Report, Corporate Update (Aug 26, 2021)

Filed August 26, 2021For Securities:COHR

Summary

Coherent Corp. (COHR), formerly II-VI Incorporated, announced an important development in its pending merger with Coherent, Inc. The company received unconditional clearance from the Federal Cartel Office in Germany, removing a significant regulatory hurdle. While this is positive news, investors should note that final competition clearances from China and South Korea are still pending. The companies maintain their expectation that the merger will close in the first calendar quarter of 2022. This 8-K filing also reiterates a comprehensive list of risks and uncertainties associated with the transaction, emphasizing that actual results may differ materially from forward-looking statements.

Key Highlights

  • 1Germany's Federal Cartel Office has granted unconditional clearance for the pending merger between II-VI Incorporated (now Coherent Corp.) and Coherent, Inc.
  • 2The merger is still awaiting competition clearances from China and South Korea.
  • 3The parties continue to anticipate the merger closing in the first calendar quarter of 2022.
  • 4The filing includes a detailed list of risks and uncertainties that could impact the successful completion and future performance of the combined entity.
  • 5Investors are encouraged to review the definitive joint proxy statement/prospectus and other SEC filings for a comprehensive understanding of the transaction and associated risks.

Frequently Asked Questions

II-VI Incorporated (now Coherent Corp.) announced it received unconditional clearance from the Federal Cartel Office in Germany on August 25, 2021. This is a significant step towards the completion of the merger.

Yes, while German regulatory approval has been secured, the merger is still awaiting competition clearances from China and South Korea.

The companies still anticipate that the merger will close during the first calendar quarter of 2022.

The filing outlines numerous risks, including the possibility of failing to obtain remaining regulatory approvals, the potential for the merger agreement to be terminated, financing challenges, difficulties in achieving expected synergies and integration, litigation, and general business and economic disruptions, including those related to the COVID-19 pandemic.